Trials / Completed
CompletedNCT03289520
Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 877 (actual)
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to determine whether clopidogrel reduces the early failure rate of native AV fistulae. This study was originally registered as NCT00067119 which included two protocols, this one and the GRAFT study)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clopidogrel | |
| DRUG | Placebo |
Timeline
- Start date
- 2003-01-07
- Primary completion
- 2007-06-18
- Completion
- 2007-06-18
- First posted
- 2017-09-21
- Last updated
- 2025-09-19
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03289520. Inclusion in this directory is not an endorsement.